NWBO

Northwest Biotherapeutics, Inc. Common stock
NWBO

Overview Fund Activity
Delisted

NWBO was delisted on the 16th of December, 2016.

Back to rankings

11 hedge funds and large institutions have $1.69M invested in Northwest Biotherapeutics, Inc. Common stock in 2023 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 3 closing their positions.

Holders
11
Holders Change
-3
Holders Change %
-21.43%
% of All Funds
0.17%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
2
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
SL
1
Sentinus LLC
Illinois
$1.4M
2
MSAM
2
Moloney Securities Asset Management
Missouri
$187K

Top Sellers

1
AA
1
Ancora Advisors
Ohio
$0
2
EFG
2
Ethos Financial Group
Pennsylvania
$0
3
GWI
3
Grace & White Inc
New York
$0
Name Market Value Shares Shares
Change 		Shares
Change %
SL
1
Sentinus LLC
Illinois
$1.4M 2,469,440 +279,000 +13%
MSAM
2
Moloney Securities Asset Management
Missouri
$187K 329,660 +45,500 +16%
OCG
3
Opus Capital Group
Ohio
$34K 60,150 – –
WJWM
4
Williams Jones Wealth Management
New York
$25K 44,000 – –
MCM
5
MAI Capital Management
Ohio
$11.4K 20,000 – –
LDB
6
Lee, Danner & Bass
Tennessee
$11K 20,000 – –
AA
7
AlphaMark Advisors
Kentucky
$8K 14,007 – –
AMG
8
Advisors Management Group
Wisconsin
$6K 10,270 – –
BCWM
9
Bartlett & Co Wealth Management
Ohio
$2.44K 4,292 – –
BC
10
Bartlett & Co
Ohio
$2K 4,292 – –
AA
11
Ancora Advisors
Ohio
– – -526,000 Closed
EFG
12
Ethos Financial Group
Pennsylvania
– – -22,200 Closed
GWI
13
Grace & White Inc
New York
– – -14,705 Closed
HFS
14
Hantz Financial Services
Michigan
$0 250 – –